Harvard researchers unveil an AI tool to precisely identify long COVID, enhancing diagnosis and patient care amid widespread post-viral illness.
A recent study from Harvard Medical School highlights how an artificial intelligence tool created by Mass General Brigham can effectively identify long COVID, also known as post-acute sequelae of COVID-19 (PASC). By analyzing electronic health records from over 295,000 patients, the AI tool demonstrated a high accuracy of 79.9%, surpassing traditional methods that often underestimate ...